Govt Extends Deadline For Pharmaceutical PLI Scheme Applications

(MENAFN- KNN India) New Delhi, Jun 18 (KNN) The Ministry of Chemicals and Fertilisers has announced an extension of the application deadline for its Production Linked Incentive (PLI) Scheme targeting domestic manufacturing of Critical Key Starting Materials (KSMs), Drug Intermediates, and Active Pharmaceutical Ingredients (APIs).

The revised deadline allows eligible applicants to submit their applications until July 4, 2025.

The Department of Pharmaceuticals issued the extension notice on June 16, 2025, referencing its previous circular from May 14, 2025.

The decision to extend the deadline is intended to provide additional time for potential applicants to prepare and submit their proposals under the scheme designed to strengthen domestic manufacturing capabilities in the pharmaceutical sector.

The PLI Scheme for Pharmaceuticals operates with a substantial budget allocation of Rs 15,000 crore and currently supports 55 domestic projects focused on advanced pharmaceutical manufacturing.

These projects encompass the production of critical medications, including treatments for cancer and diabetes, as part of the government's broader strategy to enhance domestic pharmaceutical production capacity.

The initiative includes a complementary Rs 6,940 crore PLI scheme specifically aimed at promoting domestic production of essential raw materials such as Penicillin G.

This component of the program addresses the objective of reducing India's dependence on pharmaceutical imports by building local manufacturing capabilities for key pharmaceutical inputs.

The government has also established an additional Rs 3,420 crore scheme to support the domestic manufacturing of medical devices.

This program focuses on the local production of sophisticated medical equipment including MRI machines and cardiac implants, further expanding the scope of domestic healthcare manufacturing initiatives.

The overall PLI framework represents a comprehensive approach to building India's pharmaceutical and medical device manufacturing ecosystem, with the ultimate goal of reducing import dependence while strengthening the country's position in global pharmaceutical markets.

(KNN Bureau)

MENAFN19062025000155011030ID1109694173